GS 840: The National Institute of Allergy and Infectious Diseases is sponsoring a multicenter Phase III trial

Gilead Sciences Inc. (GILD), Foster City, Calif.
Product: GS 840 (adefovir dipivoxil)

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE